期刊文献+

356株尿路感染病原菌分布及耐药性监测 被引量:2

Distribution and resistance monitoring of 356 strains of pathogenic bacteria in urinary tract infection
下载PDF
导出
摘要 目的调查普宁地区尿路感染病原菌的分布及耐药现状,为临床合理使用抗菌药物、有效控制感染提供依据。方法对2004年3月至2008年2月356株尿路感染病原菌进行鉴定和药敏试验。结果356株病原菌中大肠埃希菌居首位,占61.2%;肺炎克雷伯菌居第2位,占12.9%;凝固酶阴性葡萄球菌居第3位,占11.3%。革兰阴性病原菌除对亚胺培南、丁胺卡那霉素敏感外,对其他多种常用抗菌药物均呈不同程度的耐药,且大部分耐药率超过50.0%。结论尿路感染病原菌耐药性呈上升趋势,临床应高度重视。 Objective To investigate the distribution and drug resistance status of pathogenic bacteria in urinary tract infection in Puning district, so as to provide reference for clinical drug administration rationally. Methods Totally 258 isolates collected from urinary infection specimens from March 2004 to February 2008 were identified and then the drug susceptibility test was performed. Results The first three species in order were Escherichia coli (61.20%), Klebsiella pneumonia (12.9 % ), and coagulase-negative Staphyloecus (11.3 %). The strains of gramegative bacteria were susceptible to imipenem and amikacin, but resistant to the other common antibiotics. The resistance rate to other antibiotics was above 50%. Conclusion The drug resistance rate of isolates collected from urinary infection specimens displays an increasing tendency, which should be paid more attention by the clinicians.
出处 《检验医学与临床》 CAS 2008年第22期1361-1361,1363,共2页 Laboratory Medicine and Clinic
关键词 泌尿道感染 抗药性 微生物 微生物敏感性试验 urinary tract infection drug resistance,microbial microbial sensitivity tests
  • 相关文献

参考文献7

二级参考文献52

  • 1林茂虎,鲁鸿,贾宁.变形菌属引发导尿管相关尿路感染的研究[J].中华医院感染学杂志,2004,14(4):468-470. 被引量:25
  • 2袁宏.泌尿系感染病原菌现状及体外耐药性监测[J].中华医院感染学杂志,2005,15(1):108-109. 被引量:36
  • 3王怡芳,龚晓红,朱云霞.女性尿路感染者病原学监测[J].中华医院感染学杂志,2005,15(2):223-225. 被引量:40
  • 4贺彩芳,杨碎丽,吴雪洁,张晓晓.留置导尿腔内途径对神经科女性患者尿路逆行感染的影响[J].中华医院感染学杂志,2005,15(11):1250-1251. 被引量:13
  • 5NCCLS. Performance standards lor antimicrobial susceptibility testing[S].Ninth Informational Supplement. 1999. 19(1):36-75.
  • 6Jocoby GA, Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli[J]. Clin Microbiol, 1996, 34(4) :908-911.
  • 7Nelson EC, Elisha BG. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli [J]. Antimicrob A-gents Chemother , 1999,43 957.
  • 8Corvec S,Caroff N,Espaze E, et al. - 11 mutation in the ampC promoter increasing resistance to beta-Lactams in a Clinical Escherichia coli Strain[J] . Antimicrob Agents Chemother , 2002,46:3265.
  • 9Coudron PE, Moland ES,Thomson KS. Occurrence and detection of AmpC β- lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans' Medical Center[J] . J Clin Microbiol,2000 ,38 :1791.
  • 10Dubus A, Normarck S, Kania M, et al. The role of tyrosine 150 in catalysis of β- lactam hydrolysis by ,AmpC β-lactamase from Escherichia coli investigated by site-directed mutagenesis[J]. Biochemistry, 1994,33 : 8577.

共引文献288

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部